BUTAGEST, also known as BUTEROL,[1] as well as 3Β-HYDROXY-6-METHYL-17Α-HYDROXYPREGNA-4,6-DIEN-20-ONE 3Β-BUTANOATE 17Α-ACETATE or as 6-METHYL-17Α-HYDROXY-Δ⁶-PROGESTERONE 3Β-BUTANOATE 17Α-ACETATE, is a steroidal progestin which was developed in Russia for potential clinical use but was never marketed.[2][3][4][5][6] It is a modification of megestrol acetate in which the C3 ketone has been replaced with a C3β butanoyloxy moiety.


See also

-   Acetomepregenol
-   Clogestone
-   Clogestone acetate
-   Mecigestone


References

Category:Acetate esters Category:Butyrate esters Category:Ketones Category:Pregnanes Category:Prodrugs Category:Progestogen esters Category:Progestogens Category:Russian drugs

[1]

[2]

[3]

[4] Fedotcheva, T. A., Semeykin, A. V., Schimanowsky, N. L., & Rzheznikov, V. M. (2004, July). New progestin butagest is a perspective antiproliferative agent and chemosensitizer. In FUNDAMENTAL & CLINICAL PHARMACOLOGY (Vol. 18, pp. 84-84). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL.

[5]

[6]